Literature DB >> 6090534

The role of the transferrin receptor in human B lymphocyte activation.

L M Neckers, G Yenokida, S P James.   

Abstract

Transferrin receptors are expressed on proliferating cells and are required for their growth. Transferrin receptors can be detected after, but not before, mitogenic stimulation of normal peripheral blood T and B cells. T cells demonstrate a functional requirement for transferrin receptors in the activation process. These receptors, in turn, are induced to appear by T cell growth factor (interleukin 2). In the experiments reported here, we examined the regulation of transferrin receptor expression on activated human B cells and whether these receptors are necessary for activation to occur. Activation was assessed by studying both proliferation and immunoglobulin secretion. We determined that transferrin receptor expression on B cells is regulated by a factor contained in supernatants of mitogen-stimulated T cells (probably B cell growth factor). This expression is required for proliferation to occur, because antibody to transferrin receptor (42/6) blocks B cell proliferation. Induction of immunoglobulin secretion, however, although dependent on phytohemagglutinin-treated T cell supernatant, is not dependent on transferrin receptor expression and can occur in mitogen-stimulated cells whose proliferation has been blocked by anti-transferrin receptor antibody. These findings support a model for B cell activation in which mitogen (or antigen) delivers two concurrent but distinct signals to B cells: one, dependent on B cell growth factor and transferrin receptor expression, for proliferation; and a second, dependent on T cell-derived factors and not requiring transferrin receptors, which leads to immunoglobulin secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090534

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density.

Authors:  N Suzuki; Y Ueda; T Sakane
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 2.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

Review 3.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

Review 4.  Cross-linking the Leu-8 lymph node homing receptor on B cells inhibits immunoglobulin synthesis.

Authors:  Y Murakawa; W Strober; S P James
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

6.  Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.

Authors:  J B Trepel; O R Colamonici; K Kelly; G Schwab; R A Watt; E A Sausville; E S Jaffe; L M Neckers
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Authors:  D Wang; D Liebowitz; F Wang; C Gregory; A Rickinson; R Larson; T Springer; E Kieff
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  Inhibition of cell growth by monoclonal anti-transferrin receptor antibodies.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

9.  IL-2-like activity in lymph fluid following in vivo antigen challenge.

Authors:  R Bujdoso; P Young; J Hopkins; I McConnell
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

10.  Normal human intestinal B lymphocytes. Increased activation compared with peripheral blood.

Authors:  M G Peters; H Secrist; K R Anders; G S Nash; S R Rich; R P MacDermott
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.